Connect with us

Business

Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval – Reuters

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s…

Published

on

Article feature image
ADVERTISEMENT

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agencys decision to approve Biogen Incs (BIIB.O) Alzheimers disease treatment despite the committees recommendation against doing so.

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Teamsters to vote Thursday on sweeping push to unionize Amazon workers – CNBC
Article feature image
The New USPS Mail Truck Expected To Go Into Production In 2023 – Jalopnik
Article feature image
Wingstop leans on chicken thighs amid poultry crunch – Fox Business